These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function. Luque RM; Kineman RD Endocrinology; 2006 Jun; 147(6):2754-63. PubMed ID: 16513828 [TBL] [Abstract][Full Text] [Related]
46. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Camerino C Obesity (Silver Spring); 2009 May; 17(5):980-4. PubMed ID: 19247273 [TBL] [Abstract][Full Text] [Related]
47. The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I. Clark RG; Mortensen DL; Carlsson LM; Carlsson B; Carmignac D; Robinson IC Endocrinology; 1996 May; 137(5):1904-12. PubMed ID: 8612530 [TBL] [Abstract][Full Text] [Related]
48. Surfactant protein d deficiency in mice is associated with hyperphagia, altered fat deposition, insulin resistance, and increased basal endotoxemia. Stidsen JV; Khorooshi R; Rahbek MK; Kirketerp-Møller KL; Hansen PB; Bie P; Kejling K; Mandrup S; Hawgood S; Nielsen O; Nielsen CH; Owens T; Holmskov U; Sørensen GL PLoS One; 2012; 7(4):e35066. PubMed ID: 22509382 [TBL] [Abstract][Full Text] [Related]
50. Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY. Mashiko S; Ishihara A; Iwaasa H; Sano H; Oda Z; Ito J; Yumoto M; Okawa M; Suzuki J; Fukuroda T; Jitsuoka M; Morin NR; MacNeil DJ; Van der Ploeg LH; Ihara M; Fukami T; Kanatani A Endocrinology; 2003 May; 144(5):1793-801. PubMed ID: 12697685 [TBL] [Abstract][Full Text] [Related]